SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " liver " 4,404 found 🔀 AI-powered Shuffle
Alexander Isak: Why keeping Sweden striker fit and firing is key to Andoni Iraola's Liverpool revival
Alexander Isak heads into Sundays showdown with champions Arsenal having scored in three straight Premier League games for first time since January 2025; watch Liverpool vs Arsenal on Sunday on Sky Sports Premier League from 3.30pm; kick-off 4.30pm
Bad news as Liverpool face imminent threat over Rio Ngumoha
These are crucial hours for Liverpool’s hopes of renewing Rio Ngumoha’s contract. Now 18 the England winger has been eligible for a long-term deal since his birthday in August. Despite an agreemen...
The best Halloween movies for scaredy-cats who hate horror
Love movies? Live for TV? USA TODAY's Watch Party newsletter has all the best recommendations, delivered right to your inbox. Sign up now and be one of the cool kids.
The Easy Money Offers That Disguise a Deathtrap for Small Businesses
Merchant cash advances deliver quick funding, but some carry effective finance costs as high as 2,000%.
A computer scientist breaks through a limit that stood since 1996
A computer scientist has achieved a breakthrough in a nearly 25-year-old problem involving how computers calculate distances across enormous networks. The new algorithm delivers more reliable estimates for closely connected points without sacrificing speed, overcoming a longstanding limitation of earlier methods. Its secret lies in a smarter way of sampling network connections at multiple scales.
Patrick Stewart delivered his own eulogy in a raunchy stand-up routine 11 years before his death
Patrick Stewart jokingly penned his own eulogy for a raunchy stand-up routine 11 years before his death at 86.
DoorDash to buy Instacart for $17 billion
DoorDash announced Thursday it will buy rival Instacart for $17 billion in a deal that the company says will help local businesses compete with delivery giants such as Amazon and
Medtronic’s Diabetes Split-Off Drew a Crowd. Now MiniMed Has to Deliver.
Medtronic officially split-off MiniMed to focus on its core businesses. Investors wanted more of the stock than they had to offer.
Bengals' Zac Taylor delivers vote of confidence in rookie TE
Bengals coach Zac Taylor conveyed confidence in rookie tight end Jack Endries as Cincinnati adjusts to multiple season-ending injuries.
Starz Entertainment Corp. (STRZ) Reports Q3 Loss, Tops Revenue Estimates
Starz Entertainment Corp. (STRZ) delivered earnings and revenue surprises of -60.90% and +1.00%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
On the campaign trail, Trump delivers his greatest political hits and mourns end of rallies
President Trump is campaigning hard in the midterms. Supporters are showing up, in part because this could be the last chance to see him holding the large rallies that have been his trademark.
Starz Entertainment Corp. Reports Results for the Third Quarter Ended September 30, 2026
STARZ Delivers Sequential and Year-over-Year OTT and Total Revenue GrowthCompany Reaffirms All 2026 and 2027 TargetsSANTA MONICA, Calif. and VANCOUVER, BC, Oct. 29, 2026 /PRNewswire/ -- STARZ (NASDAQ:STRZ) today reported results for the quarter ended September 30, 2026. This press release includes…
DoorDash to buy Instacart for $17 billion
The app-based delivery service DoorDash announced a definitive agreement to acquire rival Instacart for a price of $65 per Instacart share.
Judge rules on Olivier Martinez’s restraining order against Halle Berry after abuse claims
A Los Angeles judge has ruled on Olivier Martinez’s temporary restraining order against Halle Berry in the wake of abuse claims regarding their 13-year-old son, Maceo.
Platform Science Launches Four New Fleet Apps to Streamline Operations
These new capabilities enable fleets to identify operational problems earlier, scale safety coaching across large driver rosters, share delivery visibility with customers, and take direct control of in-cab video settings – all from the back office.
Monte Carlo Launches Bayes, an AI Teammate That Fixes Production AI Agents and Their Data
The agent trust platform delivers self-improving agents, so enterprises can scale trust at the speed of AI SAN FRANCISCO, Oct. 29, 2026 — Monte Carlo has launched Bayes, an AI teammate that brings its platform capabilities into a single system to autonomously detect, troubleshoot, and fix issues across agents and the data they run on. […]
DoorDash to acquire Instacart, maintain brand identity
DoorDash's $17B acquisition of Instacart could expand delivery options, affecting gig workers' opportunities and app functionality.
Hall Reinvented Himself to Help Brewers Win World Series Title
After battling persistent injuries, DL Hall transformed his delivery and velocity and became a late-inning anchor during the Milwaukee Brewers’ historic World Series win.
Driving The Cheapest Lucid Air For 40,000 Miles Came With A Few Surprises
The most affordable Lucid doesn’t feel cheap, and it delivers all of the basics that the more expensive trims are known for.
DoorDash to buy Instacart for $17bn in major grocery delivery consolidation
Acquisition will supercharge DoorDash’s grocery delivery, ‘one of the hardest things to get right online’, CEO says
DoorDash strikes $17B deal for rival Instacart in bets on grocery delivery
DoorDash is buying grocery delivery platform Instacart as it looks to expand beyond restaurant delivery and strengthen its position in the U.S. grocery market.
DoorDash is buying Instacart for $17 billion
DoorDash is buying rival Instacart in a deal worth roughly $17 billion, signaling that the delivery wars continues to heat up.
TAAG Angloa partners with AirFi to deliver In-Flight Entertainment
TAAG Angola Airlines, the national carrier of Angola, has entered into a partnership with AirFi to deploy AirFi’s portable streaming in-flight entertainment solution (IFE) across the airline’s mixed fleet of long-haul and regional aircraft. Together, the partners aim to enhance the digital journey for TAAG Angola passengers by delivering modern in-flight entertainment services, which they […]
Decommissioned NVIDIA supercomputer with 9,600 A100 GPUs hits eBay for $60 million, free shipping included
A used NVIDIA AI cluster containing 9,600 A100 GPUs and 4,200 AMD EPYC CPUs appeared on eBay. Its $59.7 million asking price included free ground delivery.
DoorDash agrees to buy Instacart for $17 billion in a big consolidation of the grocery delivery business
SAN FRANCISCO (AP) — DoorDash agrees to buy Instacart for $17 billion in a big consolidation of the grocery delivery business.
DoorDash to Buy Instacart for $17 Billion in Big Consolidation for Grocery Delivery
DoorDash is gobbling up Instacart in a $17 billion acquisition that will supercharge its grocery delivery business. DoorDash said the Instacart brand name and app will remain, and Instacart shoppers can continue fulfilling orders for Instacart. Grocers can also choose to work with Instacart or ...
DoorDash plans to buy Instacart for $17 billion
The $17 billion deal will give DoorDash a leg up over Uber and Amazon in the world of grocery delivery.
In Creole Country, Black Residents Ask What the Fight for Voting Rights Delivers
Opelousas has shaped the fight for Black voting rights for centuries. Today, residents disagree over whether Democrats, Republicans, or racial solidarity offer a path forward.
Global Health & WASH
The US National Institutes of Health reopened its center and program-project machinery in force. NIGMS is funding Collaborative Program Grants for interdisciplinary teams, NIAID opened both its Immune Tolerance Network and a next-generation R&D call, the NCI runs its Carcinogen Hazard Assessment Monographs program, the National Library of Medicine is funding institutional training in biomedical AI and data science, and NIH reopened its Centers for AIDS Research. The tell: these pay for standing centers and multi-year consortia at institutions with an existing funded research base, not one-off projects, so the fit is an established US research institution, not a single investigator. Disease-specific foundations are again funding the researcher, not just the research. The Parkinson’s Foundation opened its Paul Oreffice Innovations in Care Award and the National Ataxia Foundation its Research Seed Money Grant. The tell, the same one we flagged last cycle, is a named early-career or seed award that builds a pipeline of scientists committed to one condition, so what wins is a researcher willing to specialize. The post-USAID global-health money is routing through a State Department program statement and multilateral innovation funds. The US Department of State’s Bureau of Global Health Security and Diplomacy opened its Advancing Global Health Annual Program Statement, Grand Challenges Canada opened Nexa Lighthouse for climate and health innovation in Asia and the Pacific at USD $250,000 to $2,000,000, and CEPI opened a rolling call on vaccine-manufacturing analytics. The tell: the largest health money this cycle sits in a standing program statement and in staged innovation vehicles, not in a single bilateral grant. Total Estimated Funding Pool: ~$35.4M across discrete grants. (Separately, large national-formula envelopes not counted in this total: U.S. Department of State, Bureau of Global Health Security and Diplomacy (GHSD).) This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. New opportunities: Paul Oreffice Innovations in Care Award, Parkinson’s Foundation. *New!* *Closing soon!* The Parkinson’s Foundation created the Paul Oreffice Innovations in Care Award to fund clinicians rethinking how people with Parkinson’s disease receive care. The Foundation is using pilot funding to move promising ideas into testable projects, backing work across four lanes: strengthening community clinician capability, redesigning care models, building patient-centered technologies, and defining the minimum clinical datasets that make better standards possible. It wants hypothesis-driven, clinically grounded projects that can generate evidence strong enough to attract further funding. By opening the door to clinicians at every career stage and strongly preferring projects that involve people with Parkinson’s in their design, the Foundation signals that it values practical, patient-shaped innovation over prestige. The strongest fits are US-licensed clinicians with a focus on Parkinson’s and an institutional home for applied care research. Geographies: united states. Who can apply: Clinicians of all career stages, from fellows to established faculty, who are licensed to care for patients in the United States and have a significant focus on Parkinson’s disease. Physicians must have completed a neurology residency (or justify how their training pathway benefits people with PD); allied health professionals must hold an advanced degree, typically a PhD. Fellows, those in mentored positions, and those within two years of starting an independent position require a mentor and a mentor support letter. The sponsoring institution’s grants office is the authorized recipient and funds are disbursed to the institution. Funding amount: Maximum of $200,000 over two years; up to three awards. Targeted Sectors / SDGs: Health; Innovation; Science & Technology. Deadline: November 1, 2026. Learn more and apply here. Design and Deliver the Next EIT Health Bootcamps, EIT Health. *New!* *Closing soon!* EIT Health is opening its call for consortia to design and deliver the next generation of its health start-up bootcamps, funding the curriculum, masterclasses, mentoring, and investor engagement that turn early health ventures into fundable companies. The organization is using these learning paths to strengthen Europe’s health innovation pipeline across digital health evidence, deep tech and AI commercialization, cross-border investment, and patient access. What EIT Health wants to back is not a single course but durable delivery capacity built by partners who span industry, education, and research. Requiring multi-country consortia and a revenue-sharing stake in the programs signals that EIT Health expects these bootcamps to outlast the grant. The strongest fits are established training providers, universities, and industry partners with proven reach into health entrepreneurs. Geographies: Europe. Who can apply: Consortia only (individuals cannot apply), comprising a minimum of two and a maximum of five independent legal entities. Partners must cover at least two sides of the Knowledge Triangle (industry, education, research), including at least one industry organisation, and at least two entities must be legally established in different Horizon Europe countries. Funding amount: Foundational Learning Path: up to EUR €112,000; Thematic Learning Paths: up to EUR €124,500 per path (up to four thematic projects); up to EUR €610,000 total EIT Health funding available under the call. Targeted Sectors / SDGs: Health; Innovation; Science & Technology; Economic Development & Livelihoods. Deadline: November 2, 2026. Learn more and apply here. Technology Transfer Offices & Entrepreneurship Support Call (Beyond the Lab: From Research to Venture), EIT Health. *New!* *Closing soon!* EIT Health is opening its Technology Transfer Offices and Entrepreneurship Support Call to fund consortia that will deliver the Beyond the Lab: From Research to Venture program for healthcare researchers. EIT Health is using the grant to build local capacity for turning laboratory science into incorporated start-ups, paying experienced technology transfer offices and entrepreneurship support providers to run masterclasses, structured mentoring, and a closing Pitch Day across two cohorts. It wants to back organizations that can walk researchers from discovery to company formation, not just teach theory. Requiring two transfer offices plus one venture-building provider signals that EIT Health values proven commercialization experience alongside academic reach. The strongest fits are European research-commercialization teams with a track record of moving health innovations toward investable ventures. Geographies: Europe. Who can apply: A consortium of two Technology Transfer Offices (representing higher education institutions or research organisations) and one Entrepreneurship Support Provider with demonstrated experience in venture building and start-up support. Applicants may apply for more than one learning path where they can demonstrate the required expertise and capacity for each. Funding amount: Up to EUR €77,000 in 2027 and up to EUR €77,000 in 2028 (up to EUR €154,000 total per consortium over two years). Targeted Sectors / SDGs: Health; Innovation; Science & Technology; Economic Development & Livelihoods. Deadline: November 2, 2026. Learn more and apply here. EIT Health RIS Country Representatives Call (2027-2028), EIT Health. *New!* *Closing soon!* EIT Health is seeking organizations to serve as Country Representatives across eleven Regional Innovation Scheme countries in central and eastern Europe for the 2027 to 2028 period. The money funds a national anchor in each country, an organization that maps the local health innovation ecosystem, connects startups and researchers to EIT Health programs, and builds the stakeholder relationships that let health ventures grow. EIT Health is backing local capacity rather than individual projects, which is why it accepts both single organizations and national consortia that span education, research, and industry. The requirement for co-financing signals that it wants representatives already embedded in their national systems. The strongest fits are established ecosystem builders with deep ties to health innovation stakeholders in one eligible country. Geographies: Croatia; Czech Republic; Estonia; Greece; Hungary; Latvia; Malta; Romania; Serbia; Slovenia; Turkey. Who can apply: Registered legal entities established in one of the eligible EIT RIS countries. Single organisations or national consortia may apply. Consortia must include at least two sides of the Knowledge Triangle (education, research and industry), and all consortium partners must be established in the same eligible country. Suitable applicants have demonstrated experience in healthcare innovation ecosystem development, innovation support and entrepreneurship, start-up acceleration, technology transfer, research and higher education, business support, and stakeholder engagement, with strong links to national innovation stakeholders. Funding amount: Up to EUR €182,000 per Country Representative (maximum funding per project); total call budget up to EUR €1,274,500; EIT Health funds up to 60% of total eligible project costs. Targeted Sectors / SDGs: Health; Innovation; Science & Technology; Economic Development & Livelihoods. Deadline: November 2, 2026. Learn more and apply here. Architects of Trust: Community-Driven Demand Creation for New TB Vaccines, Treatment Action Group (TAG). *New!* *Closing soon!* Treatment Action Group, with funding from Wellcome, is opening its Architects of Trust call to help communities prepare for the new tuberculosis vaccines now moving through late-stage trials. The money backs civil society and community-based organizations to raise awareness, surface local questions and concerns, and press policymakers toward equitable national rollout. By pairing each grantee with an advocacy mentor and running a strategy workshop alongside the Global TB Vaccine Forum, Treatment Action Group is building a durable advocacy bench rather than funding one-off outreach. The two-stage design, starting with a short expression of interest, signals that fit and community rootedness matter more than polished proposals. The strongest fits are locally trusted groups with real TB, immunization, or health advocacy experience and a committed project lead. Geographies: Brazil; Ethiopia; India; Indonesia; Kenya; Malawi; Mozambique; Nigeria; Peru; Philippines; South Africa; Tanzania; Vietnam; Zambia. Who can apply: National, subnational, or regional civil society organizations (CSOs) or community-based organizations based in one of the 14 eligible countries or in Eastern Europe/Central Asia regional networks, with experience in TB, immunization, or other health advocacy and in community engagement or policy advocacy; well integrated into stakeholder networks with membership or affiliation to other CSO or community networks; naming a dedicated project lead (’architect of trust’) who can attend the April 2027 Zaragoza forum in person; and holding (or committing to adopt) organizational policies on safeguarding (bullying, harassment, abuse, and harm), equity, diversity and inclusion, and legal compliance, research practice and governance. Funding amount: Grants of up to US$45,000 will be awarded to 8 CSO partners across 14 high-TB-burden countries plus regional networks in Eastern Europe and Central Asia; each grant funds 12 months of work. Targeted Sectors / SDGs: Health; Governance; Policy & Advocacy. Deadline: November 4, 2026. Learn more and apply here.
Lebron Helps 76ers Improve To 4-1
The Philadelphia 76ers overcame a second half collapse to defeat the Indiana Pacers 114-109 on Wednesday night, improving their record to 4-1 to begin the 2026-27 NBA season. Tyrese Maxey led the way with 27 points, while LeBron James delivered an all around performance to help Philadelphia secure an important road victory. Maxey was outstanding…
Medical waste management in home health: What agencies should consider
As more healthcare shifts from clinical settings into patients’ homes, home health agencies must consider how to safely manage waste generated during care delivery, a challenge that extends beyond their core clinical responsibilities.
Sanford to end labor and delivery services in Luverne
The announcement highlights the challenges faced by rural communities as hospitals contend with declining birth volumes, staffing demands and the need to maintain specialized maternity care.
Fed Delivers an October Surprise on Strategy, Not Politics
The FOMC maintains Fed Fund rate as Chair Kevin Warsh introduces strategy meetings.| Global Finance Magazine
Lean TECHniques reaches Select Partner Status in Claude Partner Network
Lean TECHniques, a Midwest-based software and technology consultant, has received Select Partner Status in the Claude Partner Network. Select status is the second of four tiers in the partner network and requires having a bench of Claude-certified practitioners, delivering proven use cases for clients on Claude and proving that work through customer stories and references,…
Rady Children’s Health Names Dr. Pravene Nath Chief Innovation and Physician Executive
Accomplished physician and digital health leader to accelerate innovation across research, digital health and care delivery.
‘Survivor 51’ contestants deliver searing hot takes on the franchise
‘Survivor 51’ castaways are sharing their scorching hot takes on the franchise in photo form. Plus, alums from past seasons weigh in with their own unpopular opinions.
TANUKI: Pon’s Summer adds PS5, Switch 2, and PS4 versions, launches November 10
Mail delivery adventure game TANUKI: Pon’s Summer will launch for PlayStation 5, Xbox Series, Switch 2, PlayStation 4, Xbox One, Switch, and PC via Steam on November 10, publisher CRITICAL RE…
Forsaken: Introducing Update 7.10
Meet strange traders, collect haunting mementos, deliver mysterious packages, construct an eerie corvette, jump between star systems with seamless warping and more in update 7.10, FORSAKEN! Introducing new spooky gameplay and bringing the full experience of No Man's Sky to iOS devices
Science Applications Delivers First Practical Quantum Solutions To US Agencies
SAIC delivers the first practical quantum solutions to US federal agencies, bridging the gap between science and real-world applications.
Zocdoc CEO: will AI agents make your business more valuable or more vulnerable?
Earlier this month, I sent my leadership team a memo titled “The AI Agents are Coming (Faster Than You Think).”
Alexis Mac Allister set for Liverpool exit
Alexis Mac Allister (27) looks set to leave Liverpool at the end of the season, as per a report from Franco-Belgian journalist Sacha Tavolieri. The Argentine recently said that he was upset at not hav...
National Academy of Medicine’s 2026 Annual Meeting (Scientific Symposium on Chronic Disease)
KFF Founding President and CEO Dr. Drew Altman delivered the Victor J. Dzau Keynote Address at the National Academy of Medicine’s 2026 Annual Meeting (Scientific Symposium on Chronic Disease) on October 10, 2026, where he described the big challenges ahead in health policy, and where chronic illness fits.
Riccardo Calafiori Faces 'Genuine Concern' Ahead of Liverpool Trip
Riccardo Calafiori is a doubt for Arsenal’s trip to Anfield on Sunday, though Declan Rice and Noni Madueke are expected to be available.
The Precision Peptide Company Highlights 30 Years of Peptide Science Behind Its Product Platform
HighlightsChief Scientific Officer Justin Kirkland brings three decades of hands-on peptide synthesis, analytical chemistry and formulation experience to the Company's product platformThe Company's approach centers on synthesis in the United States, an added purification step and independent third-party verificationScience-led development has already delivered the Company's needle-free BPC-157 Recovery Patch, independently tested at 95.5% purity and 2.02 mg of BPC-157 per patchVancouver, British
Ballot initiatives drive a flood of political mail
With six days to go until Election Day, the tally hasn’t been fully tolled, but it sure seems like we’re receiving more political mail this year than in previous campaigns. According to the Postal Regulatory Commission, an independent federal agency of the U.S. government, the country delivered more than 2.3 billion pieces of political mail […]
Public Health Command Europe laboratory earns renewed accreditation, strengthens force health protection
LANDSTUHL, Germany — Public Health Command Europe’s Laboratory Sciences Division has renewed its accreditation, reaffirming its ability to deliver relia...
Celtics' Paul George Quietly Delivers Something Boston Badly Needs
Jayson Tatum stole the spotlight, but Paul George provided a different kind of performance that could become increasingly valuable for the Celtics.
Comets probably didn’t deliver life’s building blocks to Earth
Most comets would have hit Earth with too much speed and at too sharp an angle for life-giving molecules to survive impact, a new study suggests.
Kuyt named Fenerbahce interim boss ahead of Liverpool tie
Former Netherlands forward Dirk Kuyt is appointed Fenerbahce’s interim coach a week before they face his former club Liverpool in the Champions League.
SAP and NTT to Cooperate on Delivering Trusted Sovereign Cloud and SAP Business AI Capabilities
TOKYO — The companies share the ambition to advance secure, resilient and sovereign digital transformation for regulated industries.
Liverpool may be sleepwalking into diabolical 2027 transfer mistake
Jose Mourinho is reportedly keen on Liverpool midfielder Alexis Mac Allister.Sky Sports Germany claim that the Argentine star is high on Real Madrid’s wishlist, with the Spanish outfit paying close ...
Baptist Health, PeriGen launch centralized OB Hub across seven delivery hospitals
In an effort to ensure mothers and babies remain monitored after delivery, Baptist Health is partnering with maternal and fetal care technology company, PeriGen
Where $205 million in rural health transformation funds is going in Wyoming
Big chunks of the federal dollars are going toward improving access to emergency care and keeping labor and delivery units open.
DoorDash soon could acquire grocery delivery service Instacart
DoorDash, the popular service that delivers meals and retail items to customers’ doors, is in talks to acquire grocery delivery platform Instacart, according to a report from the Wall Street
Caesars Entertainment (CZR) Reports Q3 Loss, Lags Revenue Estimates
Caesars Entertainment (CZR) delivered earnings and revenue surprises of -408.33% and -1.38%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Savannah Chrisley announces pregnancy and engagement to mystery fiancé
Reality star Savannah Chrisley announces her pregnancy and engagement to a mystery fiancé. The "Chrisley Knows Best" star took to social media to reveal her "sweetest blessing yet."
Opinion: Imagination infusion can help both philanthropy and nonprofits they support
Grant structures aren't always consistent with helping grantees deliver on their missions.
Baptist Health launches AI-driven platform for improving outcomes for mothers and babies
Baptist Health announced a partnership with PeriGen to launch a centralized OB Hub utilizing AI-powered technology to enhance monitoring for mothers and babies across its seven delivery hospitals.
As the new star of ‘Dracula,’ a Broadway dancer returns home to New Orleans for Halloween ballet
Oliver Halkowich, standing in socks, calls out a leap for the “horses” in his ballet. “Jeté!”
Opinion: Chicago’s push to protect gig workers threatens their independence
Chicago's delivery rules risk gig worker flexibility. States should offer portable benefits, argues an Americans for a Modern Economy adviser.
2026 U.S. Small Business Banking Satisfaction Study
TROY, Mich.: 27 Oct. 2026 — When it comes to basics such as convenience, product offerings and resolving problems, banks are delivering a consistently high level of service for their small business customers, according to the JD Power 2026 U.S. Small Business Banking Satisfaction Study,SM released today. Despite steady improvement in overall customer satisfaction, however, […]
Kingdom Come: Deliverance Developer Hit by 'Serious' Cybersecurity Incident
Warhorse Studios — the developer behind Kingdom Come: Deliverance, its sequel and an upcoming Lord of the Rings RPG — has been hit by a “serious” cyberattack.
Could meals help keep older adults from returning to the hospital?
Research found that food-insecure older adults who received two weeks of home-delivered meals after hospitalization had lower odds of early readmission.
Andoni Iraola saves Liverpool £100m thanks to genius decision
Andoni Iraola's time at Liverpool has been fairly mixed so far. While he may have only lost one game across all competitions, the Reds are still nowhere near where they need to be in terms of performa...
Payton Pritchard Leads Celtics to Dominant Win Over Bulls
The Boston Celtics delivered one of their most impressive performances of the young season Monday night, defeating the Chicago Bulls 134-99 at TD Garden. Behind a spectacular performance from Payton Pritchard and another strong showing from Jayson Tatum, Boston pulled away in the second half to secure a convincing 35 point victory. The win improved…
DoorDash in advanced talks to acquire Instacart in potential $17B deal: report
The reported talks come as DoorDash continues to expand beyond its restaurant delivery roots and Instacart competes with major retailers in the grocery delivery market.
$50B rural health fund delivers for Ohio
Rural communities have always been central to Ohio’s strength. From the farms that feed our nation to the small businesses that sustain local economies, these communities represent the hard work, resilience, and determination that define the Buckeye State. Yet for too long, the health care systems serving them have struggled with workforce shortages, financial pressures […]
Sponsored: Celebrating Nuclear Science Week
Nuclear energy plays an important role in powering our communities. This week, Entergy is celebrating the science, innovation and skilled professionals who help deliver reliable energy to Louisiana and beyond.
FF EAI Robotics Ecosystem (FFR) Completes Acquisition of FFAI Robotics Business, Establishing a Nasdaq-Listed Humanoid and Bionic Robotics Platform October Robot Sales Expected to Exceed 300 Units; Unveils FF OmniMind, a Unified AI Brain for All Robots
FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) ("FFR" or the "Company") a U.S.-based Embodied AI robotics company, today announced at the deal closing and its first Investor Day event in New York that it has completed its acquisition of the robotics business and related assets of Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) ("FFAI" or "Faraday Future") on October 23, 2026. The related business operations and assets have been transferred to FFR, and FFR has issued and delivered common sh
Cisco IQ Is the Engine. Partners Are the Business.
Cisco IQ Partner Support – Standard is now GA. Partners can now deliver Cisco IQ as their own managed service and unlock new recurring revenue.
How Eaton’s (ETN) Data Center Business Complements Amphenol’s AI Infrastructure Opportunity
Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” Q3 2026 investor letter. A copy of the letter can be downloaded here. The fund delivered strong results in the third quarter of 2026, benefiting from a sharp recovery in enterprise software and solid corporate earnings amid continued market volatility. The composite returned […]
Colton Dixon offers Christian response to Halloween with haunting new song ‘Bones’
Colton Dixon is putting a faith-filled spin on Halloween with his new single, Bones, using skeletons, graveyards and other spooky imagery to deliver a message about spiritual authority and God s
Review: The Whyte Sythe RS Delivers High-End Suspension at a Reasonable Price
A dependable option for steep, technical terrain.
Snap counts: Secondary rotation leads to success vs. Packers
The Detroit Lions delivered an inspired secondary rotation to limit the Packers’ passing attack.
📈 Monday data: The bottleneck isn’t intelligence
In the AI Investment Brief today: CapEx updates and lease commitment breakdowns Anthropic co-founder Jack Clark recently said in a speech at the IMF that the singularity has begun: For many years, researchers and science fiction authors have forecast a future in which AI systems drastically increase the pace of overall scientific and technical progress, making things move so quickly that it is hard for humans to keep up. They call this the singularity. I believe that this year we have gained convincing evidence that it has now begun. This follows Anthropic’s claim that in August, 26% of its AI R&D was led by Claude, with a human supervising its work. In October, OpenAI posted 719 math manuscripts1 made by its internal model. Math and coding are two fields where a research loop can close without leaving the desk. But can the loop close in the rest of science? Subscribe The loop is real The idea is not new. Mathematician Irving John Good, who had worked with Alan Turing at Bletchley Park, argued that a machine smarter than us “could design even better machines; there would then unquestionably be an ‘intelligence explosion,’ and the intelligence of man would be left far behind.” The Gödel machine, a self-improving computer that can rewrite its own code better than its prior, was first proposed in 2003. In 2025, researchers at Sakana AI and the University of British Columbia set out to show that this was possible. Their agents iteratively improved their own code through a feedback loop, resulting in gains of 30 pp on SWE-bench and more than 15 pp on Polyglot, testing coding skills beyond Python. The idea has since been tested in other labs. A Gemini-powered agent called AlphaEvolve found a faster matrix multiplication kernel used for training Gemini, speeding up the kernel by 23% and cutting Gemini’s training time by 1%. In China, MiniMax reported that its M2.7 model worked on improving its own agent’s harness, skills, sampling and memory. Over 100 rounds of rewriting led to a 30% gain, per its internal evaluations. In each case, what was being rewritten was not the model itself but everything around it. Is it better than human work? In September this year, in what seemed like a milestone, an AI-built agent proved as good at improving other AI agents as a human-built one. It did that in what appeared to be half the steps. But the result was inconclusive: the differences between runs were greater than the difference between the AI- and human-built agent results. Nonetheless, this is increasing the chatter around recursive self-improvement (RSI) in AI. Google’s Sundar Pichai said that “you have RSI loops along with AI researchers in various aspects of model development.” Sakana AI published a paper on RSI through multi-agent collaboration, finding that after two cycles its system scored 1.2–1.6x better per output token than the base model across four research benchmarks. Ramez Naam challenges that view. He splits AI self-improvement into five overlapping types. The first four describe how autonomous the AI is; so far, only types 1 and 2 have been observed. The fifth type describes accelerating returns, and he notes that greater autonomy doesn’t guarantee a takeoff scenario. Instead, each round of self-improvement would need to deliver at least as much as the last. The results from Sakana, AlphaEvolve and MiniMax above might look like type 3 or type 4 autonomy. But in each case, the AI wasn’t updating its own weights directly, only the ancillary parts — the harness, the memory. And where Claude leads its own R&D, for now a human still supervises.
Liverpool have dodged a transfer bullet with one smart decision
Over the last few transfer windows, it feels like almost every single player in the world has been linked with a Liverpool move. It was clear after their fifth-place finish last term that some major c...
Inside Business 2026 Top Forty Under Forty: Davis Watson, Ferguson
Davis Watson is the national head of Waterworks Digital Delivery at Ferguson Enterprises.
New Allied Health Concentration Fuses Healthcare Delivery with Emerging Technologies
The new Digital Health and Technology concentration gives UConn students firsthand experience with the tools transforming modern healthcare and build skills ...
Clune Construction: The discipline and adaptability behind our growth
Clune Construction scales nationally through innovation, employee ownership and consistent project delivery while preserving its culture.
Seahawks Jaxon Smith-Njigba Delivers Simple Message After Beating Chiefs
Seattle Seahawks wide receiver Jaxon Smith-Njigba had a simple message after his team beat the Kansas City Chiefs. The post Seahawks Jaxon Smith-Njigba Delivers Simple Message After Beating Chiefs appeared first on HEAVY.
‘Been a Problem for a Very, Very Long Time’ — Revisiting the Time Fox’s Pam Oliver Revealed the Health Battle That Impacts Her Sideline Reporting
NFL sideline reporter Pam Oliver has been a fixture in the business for more than 30 years, covering the league for Fox. At 65, she’s also one of the most experienced voices on the sidelines, most recently covering the San Francisco 49ers’ Week 7 matchup against the Atlanta Falcons.
How Functional Foods Deliver Bioactive Compounds and Support Gut Health
Functional foods use delivery systems such as encapsulation, lipid carriers, and hydrogels to protect bioactive ingredients and control their release during digestion. These technologies may improve nutrient availability, but human studies are needed to establish their health benefits and long-term safety.
How to Manage Symptoms of Heart Failure
(Feature Impact) Americans are facing a growing health challenge, with 1 in 4 adults at risk of heart failure, according to the Heart Failure Society of America. Additionally, approximately 6.7 million U.S. adults who are 20 years old or older are currently living with heart failure, and that number is projected to reach 8.7 million by 2030. googletag.cmd.push(function() { googletag.display('JGFI_Article_300x250'); }); Managing heart failure is a significant expense to the U.S. healthcare system, costing the nation approximately $40 billion in 2020 and expected to increase to approximately $142 billion a year by 2050.If you (or a loved one) are living with the condition, consider these tips to help manage it.Adhere to the Treatment and Follow-Up PlanOngoing outpatient care is important when managing heart failure. Understand the treatment plan provided by your healthcare team, make diet and lifestyle changes, take medications as directed and keep recommended follow-up appointments.Pay attention to changes in symptoms and communicate with your healthcare provider if treatment does not seem to be working as expected. If their conditions are left unmanaged, patients can experience a range of heart-failure-related symptoms such as shortness of breath, fatigue, buildup of fluid and more.Understand Challenges with Diuretic TreatmentDiuretics help the body remove excess fluid and are commonly used to treat swelling, or edema, associated with heart failure. Your provider may try different diuretics, sometimes referred to as “water pills,” to manage your heart failure symptoms. However, intravenous (IV) diuretic therapy may be required for some patients if symptoms continue.Ask About Treatment Options Before IV Care Is NeededFor some adults, a healthcare provider may consider recommending an at-home, non-oral diuretic option prior to escalating to IV therapy.For example, ENBUMYST™ (bumetanide nasal spray) is a prescription diuretic used in adults to treat edema associated with congestive heart failure. It’s administered as a nasal spray for short-term use to manage excess fluid with the goal of transitioning to oral diuretic therapy when appropriate.Talk with your healthcare provider to learn more and visit enbumyst.com. Read the full Prescribing Information and Patient Information.Photo courtesy of Shutterstock googletag.cmd.push(function() { googletag.display('JGFI_Article2_300x250'); }); Important Safety InformationWhat is ENBUMYST?ENBUMYST is a prescription medicine used in adults to treat swelling caused by excess fluid in the body (edema) from congestive heart failure, liver disease, and kidney disease.What is the most important information I should know about ENBUMYST?ENBUMYST is a diuretic that helps your body remove fluid. Losing too much fluid can cause dehydration, low blood volume, and increase the risk of blood clots. Blood abnormalities may include decreased salts (electrolytes), and increased nitrogen, glucose and uric acid. The risk of these abnormalities is higher in elderly people, those using higher doses, or those who do not get enough electrolytes by mouth.You should not use ENBUMYST if you have severe electrolyte loss. Tell your healthcare provider if you experience unusual thirst; dizziness or lightheadedness; weakness or tiredness; fast heart rate; dry mouth or tongue; sudden pain; redness or swelling in your joints; pain, swelling, redness, or warmth in your leg; shortness of breath or fast breathing; high blood sugar; dark urine; pale, tight, cool or clammy skin; muscle cramps; confusion.Do not use ENBUMYST if you have low or no urine production or are allergic to bumetanide or to any of the ingredients in ENBUMYST.Before using ENBUMYST, tell your healthcare provider if you have low electrolytes, are on a low-salt diet, have diarrhea, diabetes, nasal problems such as a runny or stuffy nose or polyps, a history of nasal injury or surgery, are or plan to become pregnant, are or plan to breastfeed.Tell your healthcare provider about all the medicines you take, including prescriptions, over-the-counter medicines, vitamins, and herbal supplements.ENBUMYST may cause serious side effects, such as worsening kidney function and ringing in the ears or hearing loss.The most common side effects of ENBUMYST include dehydration, headache, muscle cramps, dizziness, low blood pressure, nausea, and abnormal brain functioning with certain liver problems.These are not all the possible side effects of ENBUMYST. Talk to your healthcare provider for more information.Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.US-ENBU-2600110 googletag.cmd.push(function() { googletag.display('JGFI_Article3_300x250'); });
How Obama and Trump Made their Cases in Dueling Midterm Speeches
At rallies this weekend, Mr. Obama and Mr. Trump delivered two starkly contrasting pitches, differing in style and substance.
“Odegaard was outstanding” but Merson was less complimentary about Gyökeres
Paul Merson has delivered contrasting verdicts on two Arsenal players following Saturday’s comfortable 2-0 victory over Everton, singling out Martin Ødegaard for praise while questioning Viktor Gy�...
Liverpool working towards deal for star; could reach €90m
Liverpool are reportedly in the mix for a very in-demand France star. They’re working towards a deal and it’s one that could cost €90m.Liverpool are weighing up their transfer targets for the up...
How Pratt Proved Brewers Right in the World Series
Shrugging off an early error, rookie Cooper Pratt delivered a clutch game-winning hit, vindicating the Milwaukee Brewers long-term investment.
‘There's a risk we do have a disconnect’: Business on Australian Labor
Chamber of Commerce CEO Andrew McKellar appears to suddenly be everywhere, all at once.
Health care shakes up the Iowa election
If Democrats flip Congress, health care could find its way to the top of their 2027 agenda.
Apollo: AI has delivered 'zero financial payoff' to corporate America
Only tech companies are seeing growth from the AI boom, Apollo Global Management said.
Liverpool 2, Brighton 0 – Match Recap: That Was Actually Fun
A look back at the key moments in Liverpool's great victory over Brighton in Premier League action.
ESMO: Roche touts ‘convincing’ phase 3 KRAS data after win over rivals
Roche has shed more light on its investigational KRAS G12C inhibitor's phase 3 victory over Amgen’s Lumakras and Bristol Myers Squibb’s Krazati. The open-label Krascendo 1 trial enrolled 338 people with previously treated KRAS G12C-mutated non-small cell lung cancer (NSCLC). Patients who had already received a KRAS G12C inhibitor or pan-KRAS/RAS inhibitor were excluded from the trial. Participants received either divarasib once daily, Lumakras once daily or Krazati twice daily. Roche announced back in July that divarasib had demonstrated statistically significant improvements in progression-free survival (PFS) and overall survival (OS), meeting the trial’s primary and key secondary endpoints. But the Swiss pharma had been holding back the detailed data until now. At the European Society for Medical Oncology (ESMO) Congress in Madrid, Roche revealed that median OS for the 167 patients who received divarasib was 17.7 months, compared to 12 months for the 171 patients who received Lumakras or Krazati. The benefit was similarly clear when it came to median PFS, which stood at 9.8 months versus 5.7 months, respectively. A total of 44% of patients receiving divarasib were alive without disease progression at one year, compared to 24% of the control group, according to Roche’s presentation. It was a similar story for the objective response rate, which came in at 58% for divarasib versus 32% for the control group, while median duration of response was 11.9 months versus 6.9 months. Stefan Frings, M.D., Ph.D., deputy chief medical officer at Roche Pharma, told Fierce that the data made for a “very comprehensive, strong package, which should be convincing to health authorities.” “It’s an important advance for patients with lung cancer,” Frings said in an interview at a Madrid hotel during the conference. “It's a second-line setting, and patients who receive divarasib benefit compared to the current first-generation KRAS G12C inhibitors by having far longer overall survival,” he continued. “They live longer. They have better progression-free survival, better response rates, and with a safety profile which is—if [anything]—even better,” he said. According to Roche, 4.8% of patients receiving divarasib discontinued treatment due to treatment-related adverse events, compared to 11.7% in the control group. Serious treatment-related adverse events were also less common with divarasib, at 7.8% versus 15.2%. Roche’s confidence in divarasib had been building even before this phase 3 success. The candidate had already shown better potency and selectivity than the incumbent KRAS G12C inhibitors Krazati and Lumakras in preclinical tests. After cross-trial comparisons suggested that the edge translated into better clinical outcomes, Roche axed a study comparing divarasib to the chemotherapy docetaxel and went toe-to-toe with Lumakras and Krazati. “We designed the drug on purpose with higher potency and better selectivity,” Frings explained. “So, based on preclinical models, we clearly knew it would be superior to the first generation.” “It’s honestly not so frequent that pharma companies go head-to-head,” he added. “But if you want to make a point, if you want to convince payers, prescribers and patients … then a head-to-head win is rather rewarding.” While Amgen and BMS reached the regulatory finish line first for KRAS G12C-mutated, locally advanced or metastatic NSCLC in 2021 and 2022, respectively, they have struggled to capitalize on their head start. Krazati brought in $55 million for BMS in the second quarter, while Lumakras delivered $111 million to Amgen. For its part, Roche is aiming for peak divarasib sales of 1 billion to 2 billion Swiss francs ($1.2 billion to $2.5 billion), according to Frings. The Big Pharma is currently recruiting patients into a phase 3 trial comparing divarasib plus Keytruda against Keytruda plus chemotherapy in previously untreated advanced or metastatic nonsquamous KRAS G12C-mutated NSCLC. Roche has previously suggested that sales in metastatic disease would account for most of the forecast. Frings was tight-lipped on the exact timeline for a regulatory filing but said the Swiss pharma is “certainly keen to get this to as many patients as possible around the world.” Roche has more RAS drugs coming up behind divarasib. The pharma has already launched phase 1 trials of a pan-RAS inhibitor called RG6505 and a KRAS G12D inhibitor dubbed RG6620 in solid tumors. Roche’s partner Chugai Pharmaceutical is also testing a pan-KRAS inhibitor called AUBE00. Roche has made a “deliberate effort” to test a range of RAS drugs, Frings said. “If you have many rare mutations and you are scrambling to find sufficient patients, a pan-RAS inhibitor makes a lot of sense,” he explained.
South Texas Health System (@stxhealthsystem)
1 likes, 1 comments - stxhealthsystem on October 25, 2026: "Exceptional Care Starts With You: Nurses play a vital role in every patient journey, providing the compassionate, skilled care that helps make South Texas Health System’s 12 facilities a trusted healthcare resource for communities across the Rio Grande Valley. If you're passionate about making a difference and delivering exceptional patient care, now is your opportunity to join the largest integrated healthcare network in the region. STHS is seeking dedicated and compassionate registered nurses to join its team at four acute care hospitals, a behavioral health hospital and seven freestanding emergency departments. Become part of a team committed to clinical excellence, collaboration and compassionate care. To view current openings and apply, visit the STHS careers page at the link in our bio.".
9 Cool Camping Features Built Into Oliver Travel Trailers (And 3 You Can Add Yourself)
The utility you can get with an Oliver Travel Trailer these days will surely enhance your next camping trip, but there is even more than meets the eye.
Liverpool host Brighton; Man Utd take on Bournemouth in PL
2026-10-25T13:33:41ZA rundown of today's games...2pm kick-offs:Liverpool vs BrightonManchester United vs BournemouthHull City vs BrentfordCrystal Palace vs Newcastle4:30pm kick-off:Sunderland vs Leeds...
U of M fellowship aims to boost rural obstetrics training and keep labor and delivery units open
The partnership is launching the new, one-year family medicine obstetrics fellowship next summer to prepare family medicine physicians to provide advanced prenatal, maternity and newborn care in rural communities. The only other fellowship of this kind in Minnesota is at Essentia Health in Duluth.
Unfair Links Launches a Link Building Service for Local Backlinks and Google Business Profile Matched Links
Unfair Links Launches a Link Building Service for Local Backlinks and Google Business Profile Matched Links Unfair Links Launches a Link Building Service for Local Backlinks and Google Business Profile Matched Links New York City, USA, Oct. 25, 2026 (GLOBE NEWSWIRE) -- Founded by Rollo Unden and Oliver Fish, Unfair Links builds local backlinks matched to a business's Google Business Profile, country and language, and is now taking sign-ups for its beta waitlist. Unfair Links, a new link building
Liverpool and Man United contacted about transfer of wonderkid
Liverpool have a fair few positions among their ranks that still need to be upgraded. The Anfield outfit have fallen behind their title rivals quite dramatically recently with most of their players fa...
Liverpool will trigger Ronald Araujo clause on one condition
Ronald Araujo’s loan spell at Liverpool could yet become permanent.Spanish outlet Marca reports that the Reds are willing to trigger the centre-back’s £47m purchase option should his current perf...